secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001104659-23-067170
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HOOKIPA Pharma prices $50M public offering of common & convertible preferred stock
--------------------------------------------------------------------------------

- Priced 22,900,768 shares of common stock at $1.31/share and 15,268 Series A-2 convertible preferred shares at $1,310/share.
- Gross proceeds of $50M; net proceeds expected ~$46.3M after underwriting discounts and expenses.
- Offering expected to close June 5, 2023; joint book-runners are SVB Securities and RBC Capital Markets.
- Each Series A-2 preferred share converts into 1,000 common shares, non-voting, with a beneficial ownership cap of 9.99%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465923067170/0001104659-23-067170-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465923067170/tm2317399d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-067170

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer